On Monday, Century Therapeutics Inc (NASDAQ: IPSC) was 6.12% up from the session before settling in for the closing price of $0.49. A 52-week range for IPSC has been $0.34 – $1.83.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 18.46%. When this article was written, the company’s average yearly earnings per share was at 89.60%. With a float of $45.41 million, this company’s outstanding shares have now reached $86.53 million.
Century Therapeutics Inc (IPSC) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Century Therapeutics Inc stocks. The insider ownership of Century Therapeutics Inc is 47.99%, while institutional ownership is 22.80%. The most recent insider transaction that took place on Nov 20 ’25, was worth 2,736. In this transaction Chief Scientific Officer of this company sold 5,462 shares at a rate of $0.50, taking the stock ownership to the 987,027 shares. Before that another transaction happened on Nov 19 ’25, when Company’s President and CEO bought 35,000 for $0.50, making the entire transaction worth $17,328. This insider now owns 3,271,453 shares in total.
Century Therapeutics Inc (IPSC) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.35 earnings per share (EPS) during the time that was better than consensus figure (set at -0.44) by 0.08. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.3 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 89.60% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 20.63% during the next five years compared to 18.46% growth over the previous five years of trading.
Century Therapeutics Inc (NASDAQ: IPSC) Trading Performance Indicators
You can see what Century Therapeutics Inc (IPSC) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 6.25. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.40.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.31, a number that is poised to hit -0.30 in the next quarter and is forecasted to reach -1.02 in one year’s time.
Technical Analysis of Century Therapeutics Inc (IPSC)
The latest stats from [Century Therapeutics Inc, IPSC] show that its last 5-days average volume of 0.84 million was superior to 0.79 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 46.14%.
During the past 100 days, Century Therapeutics Inc’s (IPSC) raw stochastic average was set at 33.69%, which indicates a significant decrease from 56.93% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0444 in the past 14 days, which was higher than the 0.0379 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5361, while its 200-day Moving Average is $0.5580. Now, the first resistance to watch is $0.5400. This is followed by the second major resistance level at $0.5600. The third major resistance level sits at $0.5900. If the price goes on to break the first support level at $0.4900, it is likely to go to the next support level at $0.4600. Assuming the price breaks the second support level, the third support level stands at $0.4400.
Century Therapeutics Inc (NASDAQ: IPSC) Key Stats
There are 87,307K outstanding shares of the company, which has a market capitalization of 45.40 million. As of now, sales total 6,590 K while income totals -126,570 K. Its latest quarter income was 0 K while its last quarter net income were -32,540 K.
